- Home
- NKE vs REGN Comparison
NKE vs REGN Comparison
Compare NKE & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKE
- REGN
- Stock Information
- Founded
- NKE 1964
- REGN 1988
- Country
- NKE United States
- REGN United States
- Employees
- NKE N/A
- REGN N/A
- Industry
- NKE Shoe Manufacturing
- REGN Biotechnology: Pharmaceutical Preparations
- Sector
- NKE Consumer Discretionary
- REGN Health Care
- Exchange
- NKE Nasdaq
- REGN Nasdaq
- Market Cap
- NKE 106.1B
- REGN 110.0B
- IPO Year
- NKE 1980
- REGN 1991
- Fundamental
- Price
- NKE $76.51
- REGN $700.33
- Analyst Decision
- NKE Buy
- REGN Buy
- Analyst Count
- NKE 32
- REGN 26
- Target Price
- NKE $91.30
- REGN $996.00
- AVG Volume (30 Days)
- NKE 13.3M
- REGN 905.6K
- Earning Date
- NKE 03-20-2025
- REGN 02-04-2025
- Dividend Yield
- NKE 2.09%
- REGN 0.13%
- EPS Growth
- NKE N/A
- REGN 10.27
- EPS
- NKE 3.24
- REGN 38.34
- Revenue
- NKE $48,978,000,000.00
- REGN $14,202,000,000.00
- Revenue This Year
- NKE N/A
- REGN $5.20
- Revenue Next Year
- NKE $1.83
- REGN $6.39
- P/E Ratio
- NKE $23.60
- REGN $18.27
- Revenue Growth
- NKE N/A
- REGN 8.27
- 52 Week Low
- NKE $68.62
- REGN $642.00
- 52 Week High
- NKE $106.62
- REGN $1,211.20
- Technical
- Relative Strength Index (RSI)
- NKE 56.08
- REGN 52.55
- Support Level
- NKE $70.33
- REGN $655.85
- Resistance Level
- NKE $73.60
- REGN $689.95
- Average True Range (ATR)
- NKE 2.17
- REGN 21.25
- MACD
- NKE 0.50
- REGN 2.98
- Stochastic Oscillator
- NKE 82.65
- REGN 63.22
About NKE Nike Inc.
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).